MSA Life Sciences, developers of the EDITLife Transplant Management System (TMS), is pleased to be sponsoring the NMDP (National Marrow Donor Program) Council Meeting 2018 for the 3rd consecutive year. Division reps will demonstrate the state-of-the-art, EDITLife clinical workflow application at the event, which takes place November 9-10, at the Hilton in Minneapolis, MN. Bringing together the professionals who work every day to ensure the best...
Read More
Pittsburgh, PA; September 21, 2018 – Today MSA and Extract Systems announced a business partnership that provides MSA’s EDITLife Transplant Management System (TMS) users the ability to access patient data captured in unstructured documents utilizing Extract’s data extraction tools. Currently, administrative and clinical staff at many Blood and Marrow (BMT) and Solid Organ transplant centers manually enter lab values and other critical patient information into reports,...
Read More
Penn Medicine launched an innovative clinical trial in 2016 to test the effect of transplanting kidneys from donors with Hepatitis C virus (HCV) into patients currently on the kidney waitlist who do not have the virus and would opt in to receive these otherwise unused organs. After transplantation, recipients were treated with an antiviral therapy in an effort to cure the virus. To date, 20 patients have...
Read More
Nearly 2,000 children under 18 years old are on the U.S. organ transplant waiting list. Of those, approximately 500 are children ages 1 to 5. In order to raise awareness of the need for organ donors, several transplant organizations - including Transplant Families - is introducing the first annual National Pediatric Transplant Week, April 23-27. As part of National Donate Life Month, this week gives...
Read More
A novel imaging test using the imaging agent 18F-fluorothymidine (18FLT) identifies success of HSCT engraftment weeks before a traditional blood test. This imaging technique — a less painful option than bone marrow biopsies — also allowed researchers to better understand the engraftment process following HSCT. A study led by blood and marrow transplant specialists at Children's National Health System suggest that 18FLT could be useful to assess subclinical...
Read More
University of California, San Francisco, pediatric surgeons treated a fetus diagnosed with a lethal form of thalassemia, alpha thalassemia major, with stem cells from her mother's bone marrow. Born in February, the baby was the first patient enrolled in the world's first clinical trial using stems cell prior to birth. Every fetus has the perfect donor: mom. Although it is too early to say how effective the...
Read More
Using a new bioengineering process they developed and call “self-condensation,” researchers in the US and Japan are moving medical science closer to one day growing human organ tissues from tissue-engineered cells for regenerative medicine. The scientists tissue-engineered human pancreatic islets that develop a circulatory system, secrete hormones like insulin, and successfully treat sudden-onset type 1 diabetes in transplanted mice. Annually, there are 79,000 new diagnoses of type...
Read More